{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T06:29:17Z","timestamp":1793860157551,"version":"4.6.1"},"reference-count":77,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T00:00:00Z","timestamp":1783728000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T00:00:00Z","timestamp":1783728000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"the Key Scientific Research Project of Higher Education Institutions in Henan Province","award":["25A150012"],"award-info":[{"award-number":["25A150012"]}]},{"name":"the Key Scientific Research Project of Higher Education Institutions in Henan Province","award":["25B150017"],"award-info":[{"award-number":["25B150017"]}]},{"name":"Youth Project of the Natural Science Foundation of Henan Province","award":["252300421731"],"award-info":[{"award-number":["252300421731"]}]},{"name":"Youth Project of the Natural Science Foundation of Henan Province","award":["252300420805"],"award-info":[{"award-number":["252300420805"]}]},{"DOI":"10.13039\/501100006407","name":"Natural Science Foundation of Henan Province","doi-asserted-by":"publisher","award":["252300421457"],"award-info":[{"award-number":["252300421457"]}],"id":[{"id":"10.13039\/501100006407","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Scientific and Technological Innovation Talents in the Colleges and Universities in Henan Province","award":["22HASTIT050"],"award-info":[{"award-number":["22HASTIT050"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Divers"],"DOI":"10.1007\/s11030-026-11633-z","type":"journal-article","created":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T10:08:58Z","timestamp":1783764538000},"page":"10103-10131","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Integrated deep learning and multi-scale modeling for the discovery of pan-genotypic HCV NS5B polymerase inhibitors"],"prefix":"10.1007","volume":"30","author":[{"given":"Di","family":"Han","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengxiang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangbing","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhipeng","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiwei","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongkun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meiting","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiarui","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taigang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaoli","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongtao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,11]]},"reference":[{"issue":"5","key":"11633_CR1","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1016\/j.jhep.2020.07.004","volume":"73","author":"JM Pawlotsky","year":"2020","unstructured":"Pawlotsky JM, Negro F, Aghemo A, Berenguer M, Dalgard O, Dusheiko G, Marra F, Puoti M, Wedemeyer H, European Association for the Study of the Liver (2020) EASL recommendations on treatment of hepatitis C: final update of the series. J Hepatol 73(5):1170\u20131218. https:\/\/doi.org\/10.1016\/j.jhep.2020.07.004","journal-title":"J Hepatol"},{"issue":"2","key":"11633_CR2","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/S2468-1253(18)30356-4","volume":"4","author":"GS Cooke","year":"2019","unstructured":"Cooke GS, Andrieux-Meyer I, Applegate TL, Atun R, Burry JR, Cheinquer H, Dusheiko G, Feld JJ, Gore C, Griswold MG (2019) Accelerating the elimination of viral hepatitis: a Lancet Gastroenterology & Hepatology Commission. Lancet Gastroenterol Hepatol 4(2):135\u2013184. https:\/\/doi.org\/10.1016\/S2468-1253(18)30356-4","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"11633_CR3","doi-asserted-by":"publisher","first-page":"37","DOI":"10.2147\/HMER.S448735","volume":"16","author":"I Salomon","year":"2024","unstructured":"Salomon I, Olivier S, Egide N (2024) Advancing hepatitis C elimination in Africa: insights from Egypt. Hepatic Med Evid Res 16:37\u201344. https:\/\/doi.org\/10.2147\/HMER.S448735","journal-title":"Hepatic Med Evid Res"},{"issue":"Suppl 1","key":"11633_CR4","doi-asserted-by":"publisher","first-page":"S30","DOI":"10.1016\/S1665-2681(19)31384-7","volume":"9","author":"A Soza","year":"2010","unstructured":"Soza A, Riquelme A, Arrese M (2010) Routes of transmission of hepatitis C virus. Ann Hepatol 9(Suppl 1):S30\u2013S33. https:\/\/doi.org\/10.1016\/S1665-2681(19)31384-7","journal-title":"Ann Hepatol"},{"issue":"Suppl 1","key":"11633_CR5","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1111\/j.1478-3231.2008.01920.x","volume":"29","author":"D Lavanchy","year":"2009","unstructured":"Lavanchy D (2009) The global burden of hepatitis C. Liver Int 29(Suppl 1):74\u201381. https:\/\/doi.org\/10.1111\/j.1478-3231.2008.01920.x","journal-title":"Liver Int"},{"issue":"Pt 11","key":"11633_CR6","doi-asserted-by":"publisher","first-page":"3173","DOI":"10.1099\/vir.0.80401-0","volume":"85","author":"P Simmonds","year":"2004","unstructured":"Simmonds P (2004) Genetic diversity and evolution of hepatitis C virus\u201315 years on. J Gen Virol 85(Pt 11):3173\u20133188. https:\/\/doi.org\/10.1099\/vir.0.80401-0","journal-title":"J Gen Virol"},{"issue":"7","key":"11633_CR7","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.3390\/v16071115","volume":"16","author":"T Stroffolini","year":"2024","unstructured":"Stroffolini T, Stroffolini G (2024) Prevalence and modes of transmission of hepatitis C virus infection: a historical worldwide review. Viruses 16(7):1115. https:\/\/doi.org\/10.3390\/v16071115","journal-title":"Viruses"},{"key":"11633_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2147\/TCRM.S446727","volume":"20","author":"D Brigham","year":"2024","unstructured":"Brigham D, Narkewicz MR (2024) Profile of sofosbuvir and velpatasvir combination in the treatment of chronic hepatitis C in children and adolescents: current evidence. Ther Clin Risk Manag 20:1\u20137. https:\/\/doi.org\/10.2147\/TCRM.S446727","journal-title":"Ther Clin Risk Manag"},{"issue":"3","key":"11633_CR9","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1038\/nri1572","volume":"5","author":"B Rehermann","year":"2005","unstructured":"Rehermann B, Nascimbeni M (2005) Immunology of hepatitis B virus and hepatitis C virus infection. Nat Rev Immunol 5(3):215\u2013229. https:\/\/doi.org\/10.1038\/nri1572","journal-title":"Nat Rev Immunol"},{"issue":"11","key":"11633_CR10","doi-asserted-by":"publisher","first-page":"5326","DOI":"10.1128\/JVI.76.11.5326-5338.2002","volume":"76","author":"P Friebe","year":"2002","unstructured":"Friebe P, Bartenschlager R (2002) Genetic analysis of sequences in the 3\u2032 nontranslated region of hepatitis C virus that are important for RNA replication. J Virol 76(11):5326\u20135338. https:\/\/doi.org\/10.1128\/JVI.76.11.5326-5338.2002","journal-title":"J Virol"},{"issue":"4","key":"11633_CR11","doi-asserted-by":"publisher","first-page":"2046","DOI":"10.1128\/JVI.74.4.2046-2051.2000","volume":"74","author":"AA Kolykhalov","year":"2000","unstructured":"Kolykhalov AA, Mihalik K, Feinstone SM, Rice CM (2000) Hepatitis C virus-encoded enzymatic activities and conserved RNA elements in the 3\u2032 nontranslated region are essential for virus replication in vivo. J Virol 74(4):2046\u20132051. https:\/\/doi.org\/10.1128\/JVI.74.4.2046-2051.2000","journal-title":"J Virol"},{"issue":"5","key":"11633_CR12","doi-asserted-by":"publisher","first-page":"2291","DOI":"10.1073\/pnas.96.5.2291","volume":"96","author":"M Yanagi","year":"1999","unstructured":"Yanagi M, St Claire M, Emerson SU, Purcell RH, Bukh J (1999) In vivo analysis of the 3\u2032 untranslated region of the hepatitis C virus after in vitro mutagenesis of an infectious cDNA clone. Proc Natl Acad Sci U S A 96(5):2291\u20132295. https:\/\/doi.org\/10.1073\/pnas.96.5.2291","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"11633_CR13","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1006\/bbrc.1993.1464","volume":"192","author":"MR Eckart","year":"1993","unstructured":"Eckart MR, Selby M, Masiarz F, Lee C, Berger K, Crawford K, Kuo C, Kuo G, Houghton M, Choo Q (1993) The hepatitis C virus encodes a serine protease involved in processing of the putative nonstructural proteins from the viral polyprotein precursor. Biochem Biophys Res Commun 192(2):399\u2013406. https:\/\/doi.org\/10.1006\/bbrc.1993.1464","journal-title":"Biochem Biophys Res Commun"},{"issue":"5","key":"11633_CR14","doi-asserted-by":"publisher","first-page":"2832","DOI":"10.1128\/JVI.67.5.2832-2843.1993","volume":"67","author":"A Grakoui","year":"1993","unstructured":"Grakoui A, McCourt D, Wychowski C, Feinstone S, Rice C (1993) Characterization of the hepatitis C virus-encoded serine proteinase: determination of proteinase-dependent polyprotein cleavage sites. J Virol 67(5):2832\u20132843. https:\/\/doi.org\/10.1128\/JVI.67.5.2832-2843.1993","journal-title":"J Virol"},{"issue":"8","key":"11633_CR15","doi-asserted-by":"publisher","first-page":"5063","DOI":"10.1128\/JVI.68.8.5063-5073.1994","volume":"68","author":"C Lin","year":"1994","unstructured":"Lin C, Lindenbach BD, Pragai BM, McCourt DW, Rice CM (1994) Processing in the hepatitis C virus E2-NS2 region: identification of p7 and two distinct E2-specific products with different C termini. J Virol 68(8):5063\u20135073. https:\/\/doi.org\/10.1128\/JVI.68.8.5063-5073.1994","journal-title":"J Virol"},{"issue":"4","key":"11633_CR16","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1002\/hep.20819","volume":"42","author":"P Simmonds","year":"2005","unstructured":"Simmonds P, Bukh J, Combet C, Del\u00e9age G, Enomoto N, Feinstone S, Halfon P, Inchausp\u00e9 G, Kuiken C, Maertens G et al (2005) Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes. Hepatology 42(4):962\u2013973. https:\/\/doi.org\/10.1002\/hep.20819","journal-title":"Hepatology"},{"issue":"8","key":"11633_CR17","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1136\/gutjnl-2023-330124","volume":"73","author":"E Vo-Quang","year":"2024","unstructured":"Vo-Quang E, Pawlotsky JM (2024) Unusual\u2019 HCV genotype subtypes: origin, distribution, sensitivity to direct-acting antiviral drugs and behaviour on antiviral treatment and retreatment. Gut 73(8):1570\u20131582. https:\/\/doi.org\/10.1136\/gutjnl-2023-330124","journal-title":"Gut"},{"issue":"6","key":"11633_CR18","doi-asserted-by":"publisher","first-page":"e2120","DOI":"10.1002\/rmv.2120","volume":"30","author":"N Fadl","year":"2020","unstructured":"Fadl N, Salem TZ (2020) Hepatitis C genotype 4: a report on resistance-associated substitutions in NS3, NS5A, and NS5B genes. Rev Med Virol 30(6):e2120. https:\/\/doi.org\/10.1002\/rmv.2120","journal-title":"Rev Med Virol"},{"issue":"22","key":"11633_CR19","doi-asserted-by":"publisher","first-page":"12496","DOI":"10.1128\/JVI.01242-07","volume":"81","author":"S Noppornpanth","year":"2007","unstructured":"Noppornpanth S, Smits SL, Lien TX, Poovorawan Y, Osterhaus AD, Haagmans BL (2007) Characterization of hepatitis C virus deletion mutants circulating in chronically infected patients. J Virol 81(22):12496\u201312503. https:\/\/doi.org\/10.1128\/JVI.01242-07","journal-title":"J Virol"},{"issue":"1","key":"11633_CR20","doi-asserted-by":"publisher","first-page":"29","DOI":"10.7150\/ijms.3.29","volume":"3","author":"V Brass","year":"2006","unstructured":"Brass V, Moradpour D, Blum HE (2006) Molecular virology of hepatitis C virus (HCV): 2006 update. Int J Med Sci 3(1):29. https:\/\/doi.org\/10.7150\/ijms.3.29","journal-title":"Int J Med Sci"},{"issue":"2","key":"11633_CR21","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1128\/JVI.02446-13","volume":"88","author":"A Kohlway","year":"2014","unstructured":"Kohlway A, Pirakitikulr N, Barrera FN, Potapova O, Engelman DM, Pyle AM, Lindenbach BD (2014) Hepatitis C virus RNA replication and virus particle assembly require specific dimerization of the NS4A protein transmembrane domain. J Virol 88(2):628\u2013642. https:\/\/doi.org\/10.1128\/JVI.02446-13","journal-title":"J Virol"},{"issue":"3","key":"11633_CR22","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1128\/JCM.02991-14","volume":"53","author":"DG Murphy","year":"2015","unstructured":"Murphy DG, Sablon E, Chamberland J, Fournier E, Dandavino R, Tremblay CL (2015) Hepatitis C virus genotype 7, a new genotype originating from central Africa. J Clin Microbiol 53(3):967\u2013972. https:\/\/doi.org\/10.1128\/JCM.02991-14","journal-title":"J Clin Microbiol"},{"issue":"11","key":"11633_CR23","doi-asserted-by":"publisher","first-page":"1722","DOI":"10.1093\/infdis\/jiy435","volume":"218","author":"SM Borgia","year":"2018","unstructured":"Borgia SM, Hedskog C, Parhy B, Hyland RH, Stamm LM, Brainard DM, Subramanian MG, McHutchison JG, Mo H, Svarovskaia E et al (2018) Identification of a novel hepatitis C virus genotype from Punjab, India: expanding classification of hepatitis C virus into 8 genotypes. J Infect Dis 218(11):1722\u20131729. https:\/\/doi.org\/10.1093\/infdis\/jiy435","journal-title":"J Infect Dis"},{"issue":"10","key":"11633_CR24","doi-asserted-by":"publisher","first-page":"101564","DOI":"10.1016\/j.clinre.2021.101564","volume":"45","author":"JV Lazarus","year":"2021","unstructured":"Lazarus JV, Picchio CA, Guy D, Aleman S, James C, Nava FA, \u00d8vrehus A, Turnes J, Ward JW, Ustianowski A et al (2021) Hepatitis C standards of care: a review of good practices since the advent of direct-acting antiviral therapy. Clin Res Hepatol Gastroenterol 45(10):101564. https:\/\/doi.org\/10.1016\/j.clinre.2021.101564","journal-title":"Clin Res Hepatol Gastroenterol"},{"issue":"1","key":"11633_CR25","doi-asserted-by":"publisher","first-page":"30","DOI":"10.3350\/cmh.2018.0047","volume":"25","author":"N Marascio","year":"2019","unstructured":"Marascio N, Quirino A, Barreca GS, Galati L, Costa C, Pisani V, Mazzitelli M, Matera G, Liberto MC, Foc\u00e0 A (2019) Discussion on critical points for a tailored therapy to cure hepatitis C virus infection. Clin Mol Hepatol 25(1):30. https:\/\/doi.org\/10.3350\/cmh.2018.0047","journal-title":"Clin Mol Hepatol"},{"key":"11633_CR26","doi-asserted-by":"publisher","first-page":"116699","DOI":"10.1016\/j.bmc.2022.116699","volume":"60","author":"J Su","year":"2022","unstructured":"Su J, Zhai Q, Wei D (2022) Recent advancement in small molecules as HCV inhibitors. Bioorg Med Chem 60:116699. https:\/\/doi.org\/10.1016\/j.bmc.2022.116699","journal-title":"Bioorg Med Chem"},{"key":"11633_CR27","doi-asserted-by":"publisher","unstructured":"Zoratti M (2018) Guidelines for the care and treatment of persons diagnosed with chronic hepatitis C virus infection: web annex 3.1: adult hepatitis C virus treatment systematic review. https:\/\/doi.org\/10.4135\/9781526456847. World Health Organization","DOI":"10.4135\/9781526456847"},{"issue":"18","key":"11633_CR28","doi-asserted-by":"publisher","first-page":"10794","DOI":"10.1021\/acsomega.0c00724","volume":"5","author":"SD Warkad","year":"2020","unstructured":"Warkad SD, Nimse SB, Song KS, Kim T (2020) Development of a method for screening and genotyping of HCV 1a, 1b, 2, 3, 4, and 6 genotypes. ACS Omega 5(18):10794\u201310799. https:\/\/doi.org\/10.1021\/acsomega.0c00724","journal-title":"ACS Omega"},{"key":"11633_CR29","doi-asserted-by":"publisher","unstructured":"Kwong AD, Perni RB, Graham CS (2019) Development and marketing of INCIVEK (telaprevir; VX-950): a first-generation HCV protease inhibitor, in combination with PEGylated interferon and ribavirin. In: HCV: The Journey from Discovery to a Cure: Volume I. pp 261\u2013291. https:\/\/doi.org\/10.1007\/978-3-030-12243-0_10","DOI":"10.1007\/978-3-030-12243-0_10"},{"issue":"6","key":"11633_CR30","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1007\/s00018-002-8465-7","volume":"59","author":"VP Leveque","year":"2002","unstructured":"Leveque VP, Wang Q (2002) RNA-dependent RNA polymerase encoded by hepatitis C virus: biomedical applications. Cell Mol Life Sci 59(6):909\u2013919. https:\/\/doi.org\/10.1007\/s00018-002-8465-7","journal-title":"Cell Mol Life Sci"},{"issue":"12","key":"11633_CR31","doi-asserted-by":"publisher","first-page":"3867","DOI":"10.1002\/j.1460-2075.1989.tb08565.x","volume":"8","author":"O Poch","year":"1989","unstructured":"Poch O, Sauvaget I, Delarue M, Tordo N (1989) Identification of four conserved motifs among the RNA-dependent polymerase encoding elements. EMBO J 8(12):3867\u20133874. https:\/\/doi.org\/10.1002\/j.1460-2075.1989.tb08565.x","journal-title":"EMBO J"},{"issue":"11","key":"11633_CR32","doi-asserted-by":"publisher","first-page":"8416","DOI":"10.1128\/JVI.71.11.8416-8428.1997","volume":"71","author":"V Lohmann","year":"1997","unstructured":"Lohmann V, K\u00f6rner F, Herian U, Bartenschlager R (1997) Biochemical properties of hepatitis C virus NS5B RNA-dependent RNA polymerase and identification of amino acid sequence motifs essential for enzymatic activity. J Virol 71(11):8416\u20138428. https:\/\/doi.org\/10.1128\/JVI.71.11.8416-8428.1997","journal-title":"J Virol"},{"issue":"10","key":"11633_CR33","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1007\/s10822-021-00412-7","volume":"35","author":"AA Malik","year":"2021","unstructured":"Malik AA, Chotpatiwetchkul W, Phanus-Umporn C, Nantasenamat C, Charoenkwan P, Shoombuatong W (2021) StackHCV: a web-based integrative machine-learning framework for large-scale identification of hepatitis C virus NS5B inhibitors. J Comput Aided Mol Des 35(10):1037\u20131053. https:\/\/doi.org\/10.1007\/s10822-021-00412-7","journal-title":"J Comput Aided Mol Des"},{"key":"11633_CR34","doi-asserted-by":"publisher","first-page":"116832","DOI":"10.1016\/j.ejmech.2024.116832","volume":"279","author":"M Camci","year":"2024","unstructured":"Camci M, \u015eenol H, Kose A, Mayack BK, Alayoubi MM, Karali N, Gezginci MH (2024) Bioisosteric replacement of the carboxylic acid group in hepatitis-C virus NS5B thumb site II inhibitors: phenylalanine derivatives. Eur J Med Chem 279:116832. https:\/\/doi.org\/10.1016\/j.ejmech.2024.116832","journal-title":"Eur J Med Chem"},{"key":"11633_CR35","doi-asserted-by":"publisher","DOI":"10.1080\/07391102.2020.1867947","author":"P Polamreddy","year":"2020","unstructured":"Polamreddy P, Vishwakarma V, Arumugam P, Bheemanati R, Esram P, Mahto MK, Kacker P (2020) Discovery of hit molecules targeting allosteric site of hepatitis C virus NS5B polymerase. J Biomol Struct Dyn. https:\/\/doi.org\/10.1080\/07391102.2020.1867947","journal-title":"J Biomol Struct Dyn"},{"key":"11633_CR36","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.ejmech.2012.09.040","volume":"58","author":"AG Golub","year":"2012","unstructured":"Golub AG, Gurukumar K, Basu A, Bdzhola VG, Bilokin Y, Yarmoluk SM, Lee JC, Talele TT, Nichols DB, Kaushik-Basu N (2012) Discovery of new scaffolds for rational design of HCV NS5B polymerase inhibitors. Eur J Med Chem 58:258\u2013264. https:\/\/doi.org\/10.1016\/j.ejmech.2012.09.040","journal-title":"Eur J Med Chem"},{"issue":"14","key":"11633_CR37","doi-asserted-by":"publisher","first-page":"8028","DOI":"10.3390\/ijms25148028","volume":"25","author":"D Han","year":"2024","unstructured":"Han D, Zhao F, Chen Y, Xue Y, Bao K, Chang Y, Lu J, Wang M, Liu T, Gao Q (2024) Distinct characteristic binding modes of benzofuran core inhibitors to diverse genotypes of hepatitis C virus NS5B polymerase: a molecular simulation study. Int J Mol Sci 25(14):8028. https:\/\/doi.org\/10.3390\/ijms25148028","journal-title":"Int J Mol Sci"},{"issue":"8","key":"11633_CR38","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.4155\/fmc.11.66","volume":"3","author":"ML Barreca","year":"2011","unstructured":"Barreca ML, Iraci N, Manfroni G, Cecchetti V (2011) Allosteric inhibition of the hepatitis C virus NS5B polymerase: in silico strategies for drug discovery and development. Future Med Chem 3(8):1027\u20131055. https:\/\/doi.org\/10.4155\/fmc.11.66","journal-title":"Future Med Chem"},{"issue":"12","key":"11633_CR39","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1021\/acsmedchemlett.8b00405","volume":"9","author":"KS Yeung","year":"2018","unstructured":"Yeung KS, Beno BR, Mosure K, Zhu J, Grant-Young KA, Parcella K, Anjanappa P, Bora RO, Selvakumar K, Wang YK et al (2018) Structure\u2013property basis for solving transporter-mediated efflux and pan-genotypic inhibition in HCV NS5B inhibitors. ACS Med Chem Lett 9(12):1217\u20131222. https:\/\/doi.org\/10.1021\/acsmedchemlett.8b00405","journal-title":"ACS Med Chem Lett"},{"issue":"9","key":"11633_CR40","doi-asserted-by":"publisher","first-page":"4525","DOI":"10.1128\/AAC.00402-12","volume":"56","author":"J de Bruijne","year":"2012","unstructured":"de Bruijne J, van de Wetering J, van Vliet AA, Zhou XJ, Temam MF, Molles J, Chen J, Pietropaolo K, Sullivan-B\u00f3lyai JZ, Mayers D et al (2012) First-in-human study of the pharmacokinetics and antiviral activity of IDX375, a novel nonnucleoside hepatitis C virus polymerase inhibitor. Antimicrob Agents Chemother 56(9):4525\u20134528. https:\/\/doi.org\/10.1128\/AAC.00402-12","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"11633_CR41","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1128\/AAC.01022-08","volume":"53","author":"M Flint","year":"2009","unstructured":"Flint M, Mullen S, Deatly AM, Chen W, Miller LZ, Ralston R, Broom C, Emini EA, Howe AY (2009) Selection and characterization of hepatitis C virus replicons dually resistant to the polymerase and protease inhibitors HCV-796 and boceprevir (SCH 503034). Antimicrob Agents Chemother 53(2):401\u2013411. https:\/\/doi.org\/10.1128\/AAC.01022-08","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"11633_CR42","doi-asserted-by":"publisher","first-page":"1902","DOI":"10.1021\/jm401727z","volume":"57","author":"A Maynard","year":"2014","unstructured":"Maynard A, Crosby RM, Ellis B, Hamatake R, Hong Z, Johns BA, Kahler KM, Koble C, Leivers A, Leivers MR et al (2014) Discovery of a potent boronic acid derived inhibitor of the HCV RNA-dependent RNA polymerase. J Med Chem 57(5):1902\u20131913. https:\/\/doi.org\/10.1021\/jm401727z","journal-title":"J Med Chem"},{"issue":"1","key":"11633_CR43","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1111\/jvh.12782","volume":"25","author":"S Gardner","year":"2018","unstructured":"Gardner S, Kim J, Baptiste-Brown S, Lopez V, Hamatake R, Gan J, Edwards S, Elko-Simms L, Dumont E, Leivers M et al (2018) GSK 2878175, a pan-genotypic non\u2010nucleoside NS 5B polymerase inhibitor, in healthy and treatment\u2010na\u00efve chronic hepatitis C subjects. J Viral Hepat 25(1):19\u201327. https:\/\/doi.org\/10.1111\/jvh.12782","journal-title":"J Viral Hepat"},{"issue":"17","key":"11633_CR44","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1002\/cmdc.201700312","volume":"12","author":"CC McComas","year":"2017","unstructured":"McComas CC, Palani A, Chang W, Holloway MK, Lesburg CA, Li P, Liverton N, Meinke PT, Olsen DB, Peng X et al (2017) Development of a new structural class of broadly acting HCV non-nucleoside inhibitors leading to the discovery of MK\u20108876. ChemMedChem 12(17):1436\u20131448. https:\/\/doi.org\/10.1002\/cmdc.201700312","journal-title":"ChemMedChem"},{"issue":"18","key":"11633_CR45","doi-asserted-by":"publisher","first-page":"126104","DOI":"10.1016\/j.bmcl.2019.126104","volume":"29","author":"H Liu","year":"2019","unstructured":"Liu H, Dai X, He S, Brockunier L, Marcantonio K, Ludmerer SW, Li F, Feng KI, Nargund RP, Palani A (2019) Design and evaluation of novel tetracyclic benzofurans as palm site allosteric inhibitors of HCV NS5B polymerase. Bioorg Med Chem Lett 29(18):126104. https:\/\/doi.org\/10.1016\/j.bmcl.2019.126104","journal-title":"Bioorg Med Chem Lett"},{"issue":"10","key":"11633_CR46","doi-asserted-by":"publisher","first-page":"4369","DOI":"10.1021\/acs.jmedchem.7b00219","volume":"60","author":"KS Yeung","year":"2017","unstructured":"Yeung KS, Beno BR, Parcella K, Bender JA, Grant-Young KA, Nickel A, Gunaga P, Anjanappa P, Bora RO, Selvakumar K et al (2017) Discovery of a hepatitis C virus NS5B replicase palm site allosteric inhibitor (BMS-929075) advanced to phase 1 clinical studies. J Med Chem 60(10):4369\u20134385. https:\/\/doi.org\/10.1021\/acs.jmedchem.7b00219","journal-title":"J Med Chem"},{"issue":"4","key":"11633_CR47","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1039\/C7MD00021A","volume":"8","author":"KJ Eastman","year":"2017","unstructured":"Eastman KJ, Parcella K, Yeung KS, Grant-Young KA, Zhu J, Wang T, Zhang Z, Yin Z, Beno BR, Sheriff S et al (2017) The discovery of a pan-genotypic, primer grip inhibitor of HCV NS5B polymerase. MedChemComm 8(4):796\u2013806. https:\/\/doi.org\/10.1039\/C7MD00021A","journal-title":"MedChemComm"},{"issue":"5","key":"11633_CR48","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1016\/j.bmcl.2018.01.051","volume":"28","author":"M Zhong","year":"2018","unstructured":"Zhong M, Peng E, Huang N, Huang Q, Huq A, Lau M, Colonno R, Li L (2018) Discovery of novel potent HCV NS5B polymerase non-nucleoside inhibitors bearing a fused benzofuran scaffold. Bioorg Med Chem Lett 28(5):963\u2013968. https:\/\/doi.org\/10.1016\/j.bmcl.2018.01.051","journal-title":"Bioorg Med Chem Lett"},{"issue":"5","key":"11633_CR49","doi-asserted-by":"publisher","first-page":"103516","DOI":"10.1016\/j.drudis.2023.103516","volume":"28","author":"C Cerchia","year":"2023","unstructured":"Cerchia C, Lavecchia A (2023) New avenues in artificial-intelligence-assisted drug discovery. Drug Discov Today 28(5):103516. https:\/\/doi.org\/10.1016\/j.drudis.2023.103516","journal-title":"Drug Discov Today"},{"issue":"7553","key":"11633_CR50","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1038\/nature14539","volume":"521","author":"Y LeCun","year":"2015","unstructured":"LeCun Y, Bengio Y, Hinton G (2015) Deep learning. Nature 521(7553):436\u2013444. https:\/\/doi.org\/10.1038\/nature14539","journal-title":"Nature"},{"key":"11633_CR51","doi-asserted-by":"publisher","unstructured":"Cho Y, Rangel G, Bhardwaj G, Ovchinnikov S (2025) Protein Hunter: exploiting structure hallucination within diffusion for protein design. https:\/\/doi.org\/10.1101\/2025.10.10.681530. bioRxiv:2025.10.10.681530","DOI":"10.1101\/2025.10.10.681530"},{"issue":"8016","key":"11633_CR52","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1038\/s41586-024-07487-w","volume":"630","author":"J Abramson","year":"2024","unstructured":"Abramson J, Adler J, Dunger J, Evans R, Green T, Pritzel A, Ronneberger O, Willmore L, Ballard AJ, Bambrick J et al (2024) Accurate structure prediction of biomolecular interactions with AlphaFold 3. Nature 630(8016):493\u2013500. https:\/\/doi.org\/10.1038\/s41586-024-07487-w","journal-title":"Nature"},{"issue":"12","key":"11633_CR53","doi-asserted-by":"publisher","first-page":"3671","DOI":"10.3390\/ijms26123671","volume":"26","author":"MG Krokidis","year":"2025","unstructured":"Krokidis MG, Koumadorakis DE, Lazaros K, Ivantsik O, Exarchos TP, Vrahatis AG, Kotsiantis S, Vlamos P (2025) AlphaFold3: an overview of applications and performance insights. Int J Mol Sci 26(12):3671. https:\/\/doi.org\/10.3390\/ijms26123671","journal-title":"Int J Mol Sci"},{"issue":"1","key":"11633_CR54","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/s13321-021-00562-1","volume":"13","author":"X Liu","year":"2021","unstructured":"Liu X, Ye K, van Vlijmen HW, Emmerich MT, IJzerman AP, van Westen GJ (2021) DrugEx v2: de novo design of drug molecules by Pareto-based multi-objective reinforcement learning in polypharmacology. J Cheminform 13(1):85. https:\/\/doi.org\/10.1186\/s13321-021-00562-1","journal-title":"J Cheminform"},{"issue":"D1","key":"11633_CR55","doi-asserted-by":"publisher","first-page":"D930","DOI":"10.1093\/nar\/gky1075","volume":"47","author":"D Mendez","year":"2019","unstructured":"Mendez D, Gaulton A, Bento AP, Chambers J, De Veij M, F\u00e9lix E, Magari\u00f1os MP, Mosquera JF, Mutowo P, Nowotka M et al (2019) ChEMBL: towards direct deposition of bioassay data. Nucleic Acids Res 47(D1):D930\u2013D940. https:\/\/doi.org\/10.1093\/nar\/gky1075","journal-title":"Nucleic Acids Res"},{"issue":"10","key":"11633_CR56","doi-asserted-by":"publisher","first-page":"4385","DOI":"10.1021\/acs.jmedchem.5b01680","volume":"59","author":"N Schneider","year":"2016","unstructured":"Schneider N, Lowe DM, Sayle RA, Tarselli MA, Landrum GA (2016) Big data from pharmaceutical patents: a computational analysis of medicinal chemists\u2019 bread and butter. J Med Chem 59(10):4385\u20134402. https:\/\/doi.org\/10.1021\/acs.jmedchem.5b01680","journal-title":"J Med Chem"},{"issue":"W1","key":"11633_CR57","doi-asserted-by":"publisher","first-page":"W296","DOI":"10.1093\/nar\/gky427","volume":"46","author":"A Waterhouse","year":"2018","unstructured":"Waterhouse A, Bertoni M, Bienert S, Studer G, Tauriello G, Gumienny R, Heer FT, de Beer TAP, Rempfer C, Bordoli L et al (2018) SWISS-MODEL: homology modelling of protein structures and complexes. Nucleic Acids Res 46(W1):W296\u2013W303. https:\/\/doi.org\/10.1093\/nar\/gky427","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"11633_CR58","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13065-025-01234-5","volume":"19","author":"D Han","year":"2025","unstructured":"Han D, Xue Y, Zhao F, Liu F, Xia H, Lu J, Wang M, Liu T, Cui S, Zhao J et al (2025) Virtual screening, optimization design, and synthesis analysis of novel benzofuran derivatives as pan-genotypic HCV NS5B polymerase inhibitors using molecular modeling. BMC Chem 19(1):1\u201327. https:\/\/doi.org\/10.1186\/s13065-025-01234-5","journal-title":"BMC Chem"},{"issue":"9","key":"11633_CR59","doi-asserted-by":"publisher","first-page":"4216","DOI":"10.1021\/acs.jcim.0c00402","volume":"60","author":"WL Ye","year":"2020","unstructured":"Ye WL, Shen C, Xiong GL, Ding JJ, Lu AP, Hou TJ, Cao DS (2020) Improving docking-based virtual screening ability by integrating multiple energy auxiliary terms from molecular docking scoring. J Chem Inf Model 60(9):4216\u20134230. https:\/\/doi.org\/10.1021\/acs.jcim.0c00402","journal-title":"J Chem Inf Model"},{"issue":"7","key":"11633_CR60","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1007\/s10822-012-9577-3","volume":"26","author":"CR Corbeil","year":"2012","unstructured":"Corbeil CR, Williams CI, Labute P (2012) Variability in docking success rates due to dataset preparation. J Comput Aided Mol Des 26(7):775\u2013786. https:\/\/doi.org\/10.1007\/s10822-012-9577-3","journal-title":"J Comput Aided Mol Des"},{"issue":"5","key":"11633_CR61","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1021\/ci9803381","volume":"39","author":"SA Wildman","year":"1999","unstructured":"Wildman SA, Crippen GM (1999) Prediction of physicochemical parameters by atomic contributions. J Chem Inf Comput Sci 39(5):868\u2013873. https:\/\/doi.org\/10.1021\/ci9803381","journal-title":"J Chem Inf Comput Sci"},{"issue":"1","key":"11633_CR62","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1758-2946-1-8","volume":"1","author":"P Ertl","year":"2009","unstructured":"Ertl P, Schuffenhauer A (2009) Estimation of synthetic accessibility score of drug-like molecules based on molecular complexity and fragment contributions. J Cheminform 1(1):1\u201311. https:\/\/doi.org\/10.1186\/1758-2946-1-8","journal-title":"J Cheminform"},{"issue":"2","key":"11633_CR63","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1038\/nchem.1243","volume":"4","author":"GR Bickerton","year":"2012","unstructured":"Bickerton GR, Paolini GV, Besnard J, Muresan S, Hopkins AL (2012) Quantifying the chemical beauty of drugs. Nat Chem 4(2):90\u201398. https:\/\/doi.org\/10.1038\/nchem.1243","journal-title":"Nat Chem"},{"issue":"17","key":"11633_CR64","doi-asserted-by":"publisher","first-page":"10091","DOI":"10.1021\/acs.jmedchem.0c00699","volume":"63","author":"CP Tinworth","year":"2020","unstructured":"Tinworth CP, Young RJ (2020) Facts, patterns, and principles in drug discovery: appraising the rule of 5 with measured physicochemical data. J Med Chem 63(17):10091\u201310108. https:\/\/doi.org\/10.1021\/acs.jmedchem.0c00699","journal-title":"J Med Chem"},{"issue":"W1","key":"11633_CR65","doi-asserted-by":"publisher","first-page":"W422","DOI":"10.1093\/nar\/gkae327","volume":"52","author":"L Fu","year":"2024","unstructured":"Fu L, Shi S, Yi J, Wang N, He Y, Wu Z, Peng J, Deng Y, Wang W, Wu C et al (2024) ADMETlab 3.0: an updated comprehensive online ADMET prediction platform enhanced with broader coverage, improved performance, API functionality and decision support. Nucleic Acids Res 52(W1):W422\u2013W431. https:\/\/doi.org\/10.1093\/nar\/gkae327","journal-title":"Nucleic Acids Res"},{"issue":"2","key":"11633_CR66","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1002\/wcms.1121","volume":"3","author":"R Salomon-Ferrer","year":"2013","unstructured":"Salomon-Ferrer R, Case DA, Walker RC (2013) An overview of the Amber biomolecular simulation package. Wiley Interdiscip Rev Comput Mol Sci 3(2):198\u2013210. https:\/\/doi.org\/10.1002\/wcms.1121","journal-title":"Wiley Interdiscip Rev Comput Mol Sci"},{"issue":"12","key":"11633_CR67","doi-asserted-by":"publisher","first-page":"5595","DOI":"10.1021\/acs.jcim.0c00854","volume":"60","author":"TS Lee","year":"2020","unstructured":"Lee TS, Allen BK, Giese TJ, Guo Z, Li P, Lin C, McGee TD Jr, Pearlman DA, Radak BK, Tao Y et al (2020) Alchemical binding free energy calculations in AMBER20: advances and best practices for drug discovery. J Chem Inf Model 60(12):5595\u20135623. https:\/\/doi.org\/10.1021\/acs.jcim.0c00854","journal-title":"J Chem Inf Model"},{"issue":"18","key":"11633_CR68","doi-asserted-by":"publisher","first-page":"5882","DOI":"10.1021\/acs.jpcb.5b00744","volume":"119","author":"K Sprenger","year":"2015","unstructured":"Sprenger K, Jaeger VW, Pfaendtner J (2015) The general AMBER force field (GAFF) can accurately predict thermodynamic and transport properties of many ionic liquids. J Phys Chem B 119(18):5882\u20135895. https:\/\/doi.org\/10.1021\/acs.jpcb.5b00744","journal-title":"J Phys Chem B"},{"issue":"8","key":"11633_CR69","doi-asserted-by":"publisher","first-page":"3696","DOI":"10.1021\/acs.jctc.5b00255","volume":"11","author":"JA Maier","year":"2015","unstructured":"Maier JA, Martinez C, Kasavajhala K, Wickstrom L, Hauser KE, Simmerling C (2015) ff14SB: improving the accuracy of protein side chain and backbone parameters from ff99SB. J Chem Theory Comput 11(8):3696\u20133713. https:\/\/doi.org\/10.1021\/acs.jctc.5b00255","journal-title":"J Chem Theory Comput"},{"issue":"12","key":"11633_CR70","doi-asserted-by":"publisher","first-page":"124105","DOI":"10.1063\/1.3643444","volume":"135","author":"S Roy Kimura","year":"2011","unstructured":"Roy Kimura S, Rajamani R, Langley DR (2011) Communication: quantum polarized fluctuating charge model: a practical method to include ligand polarizability in biomolecular simulations. J Chem Phys 135(12):124105. https:\/\/doi.org\/10.1063\/1.3643444","journal-title":"J Chem Phys"},{"issue":"2","key":"11633_CR71","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.jmgm.2005.12.005","volume":"25","author":"J Wang","year":"2006","unstructured":"Wang J, Wang W, Kollman PA, Case DA (2006) Automatic atom type and bond type perception in molecular mechanical calculations. J Mol Graph Model 25(2):247\u2013260. https:\/\/doi.org\/10.1016\/j.jmgm.2005.12.005","journal-title":"J Mol Graph Model"},{"issue":"12","key":"11633_CR72","doi-asserted-by":"publisher","first-page":"124104","DOI":"10.1063\/1.5025133","volume":"148","author":"S Mamatkulov","year":"2018","unstructured":"Mamatkulov S, Schwierz N (2018) Force fields for monovalent and divalent metal cations in TIP3P water based on thermodynamic and kinetic properties. J Chem Phys 148(12):124104. https:\/\/doi.org\/10.1063\/1.5025133","journal-title":"J Chem Phys"},{"issue":"31","key":"11633_CR73","doi-asserted-by":"publisher","first-page":"16719","DOI":"10.1039\/C4CP01487A","volume":"16","author":"H Sun","year":"2014","unstructured":"Sun H, Li Y, Tian S, Xu L, Hou T (2014) Assessing the performance of MM\/PBSA and MM\/GBSA methods. 4. Accuracies of MM\/PBSA and MM\/GBSA methodologies evaluated by various simulation protocols using PDBbind data set. Phys Chem Chem Phys 16(31):16719\u201316729. https:\/\/doi.org\/10.1039\/C4CP01487A","journal-title":"Phys Chem Chem Phys"},{"issue":"1","key":"11633_CR74","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1021\/ci100279b","volume":"51","author":"T Hou","year":"2011","unstructured":"Hou T, Wang J, Li Y, Wang W (2011) Assessing the performance of the MM\/PBSA and MM\/GBSA methods. 1. The accuracy of binding free energy calculations based on molecular dynamics simulations. J Chem Inf Model 51(1):69\u201382. https:\/\/doi.org\/10.1021\/ci100279b","journal-title":"J Chem Inf Model"},{"issue":"20","key":"11633_CR75","doi-asserted-by":"publisher","first-page":"5904","DOI":"10.1002\/anie.201507667","volume":"55","author":"S Szymku\u0107","year":"2016","unstructured":"Szymku\u0107 S, Gajewska EP, Klucznik T, Molga K, Dittwald P, Startek M, Bajczyk M, Grzybowski BA (2016) Computer-assisted synthetic planning: the end of the beginning. Angew Chem Int Ed 55(20):5904\u20135937. https:\/\/doi.org\/10.1002\/anie.201507667","journal-title":"Angew Chem Int Ed"},{"issue":"1","key":"11633_CR76","doi-asserted-by":"publisher","first-page":"e84808","DOI":"10.1371\/journal.pone.0084808","volume":"9","author":"SE Boyce","year":"2014","unstructured":"Boyce SE, Tirunagari N, Niedziela-Majka A, Perry J, Wong M, Kan E, Lagpacan L, Barauskas O, Hung M, Fenaux M et al (2014) Structural and regulatory elements of HCV NS5B polymerase\u2013\u03b2-loop and C-terminal tail\u2013are required for activity of allosteric thumb site II inhibitors. PLoS ONE 9(1):e84808. https:\/\/doi.org\/10.1371\/journal.pone.0084808","journal-title":"PLoS ONE"},{"issue":"8","key":"11633_CR77","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.1016\/j.bpj.2015.02.031","volume":"108","author":"BC Davis","year":"2015","unstructured":"Davis BC, Brown JA, Thorpe IF (2015) Allosteric inhibitors have distinct effects, but also common modes of action, in the HCV polymerase. Biophys J 108(8):1785\u20131795. https:\/\/doi.org\/10.1016\/j.bpj.2015.02.031","journal-title":"Biophys J"}],"container-title":["Molecular Diversity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11030-026-11633-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11030-026-11633-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11030-026-11633-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T06:05:08Z","timestamp":1793858708000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11030-026-11633-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,11]]},"references-count":77,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["11633"],"URL":"https:\/\/doi.org\/10.1007\/s11030-026-11633-z","relation":{},"ISSN":["1573-501X"],"issn-type":[{"value":"1573-501X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,11]]},"assertion":[{"value":"12 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interest.","order":1,"name":"Ethics","label":"Competing interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Informed Consent","group":{"name":"EthicsHeading","label":"Declarations"}}]}}